Oncology & Cancer

Allo-HCT with unrelated donor tied to better outcomes in AML

(HealthDay)—Allogeneic hematopoietic cell transplantation (allo-HCT) with an unrelated donor (UD) results in better transplantation outcomes than cord blood transplantation (CBT) in acute myeloid leukemia (AML) patients ...

Medical research

A repurposed drug could open door to more stem cell transplants

A medication used to treat joint and skin conditions might also help people whose only hope of surviving cancer is receiving stem cells from a donor, according to research by a University of British Columbia scientist.

Medical research

The life-saving treatment that's being thrown in the trash

A few hours before beginning chemotherapy, a man named Chris faces his cellphone camera with a mischievous smile and describes a perfectly absurd milestone at 1.37pm on a Wednesday. "There is no more beautiful moment in a ...

Medical research

Discovery improves use of umbilical cord blood as cancer therapy

A clinician/scientist, who studies ways to make cord-blood transplants for leukemia and lymphoma patients safer and more effective, recently reported a new finding in the journal Blood. An accompanying editorial called the ...

Medical research

Human trials of manufactured blood within two years

The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant. Research led by scientists at the University of Bristol ...

page 1 from 3